SCZ 18.10, hvs483

General

Cell Line

hPSCreg name VUi002-A
Cite as:
VUi002-A (RRID:CVCL_ZB03)
Alternative name(s)
SCZ 18.10, hvs483
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
VUi001-A
(SCZ 14.3, hvs479)
Donor diseases:
Schizophrenia
VUi011-A
(SCZ 3.5)
Donor diseases:
Schizophrenia
VUi089-A
(hvs-481, 16.1)
Donor diseases:
Schizophrenia
VUi014-A
(SCZ 11.8, hvs476)
Donor diseases:
Schizophrenia
VUi016-A
(789.A1, hvs341)
Donor diseases:
Schizophrenia
VUi018-A
(SCZ 5.1, hvs487)
Donor diseases:
Schizophrenia
VUi019-A
(SCZ 15.2, hvs480)
Donor diseases:
Schizophrenia
VUi020-A
(SCZ 20.1, hvs485)
Donor diseases:
Schizophrenia
VUi021-A
(793.3, hvs473)
Donor diseases:
Schizophrenia
VUi093-A
(hvs472, 771.1)
Donor diseases:
Schizophrenia
VUi034-A
(hvs-304, SCZ 8.1)
Donor diseases:
Schizophrenia
VUi035-A
(hvs-471, SCZ 802.2A)
Donor diseases:
Schizophrenia
VUi047-A
(785.10, hvs337)
Donor diseases:
Schizophrenia
VUi049-A
(790.3, hvs470)
Donor diseases:
Schizophrenia
VUi053-A
(2.5, hvs317)
Donor diseases:
Schizophrenia
VUi003-A
(SCZ 13.2, hvs478)
Donor diseases:
Schizophrenia
VUi004-A
(SCZ 19.2, hvs-484)
Donor diseases:
Schizophrenia
VUi052-A
(17.6, hvs482)
Donor diseases:
Schizophrenia
PNUi004-A
Donor diseases:
Schizophrenia
PNUi004-B
Donor diseases:
Schizophrenia
PNUi004-C
Donor diseases:
Schizophrenia
UJSi004-A
Donor diseases:
Schizophrenia
JNMUi003-A
(iPSCs—PB-SCZ-70#-C1P19)
Donor diseases:
Schizophrenia
JNMUi001-A
(JNMUi001-A)
Donor diseases:
Schizophrenia
MLUi001-M
Donor diseases:
Schizophrenia
MLUi002-G
Donor diseases:
Schizophrenia
JNMUi002-A
(JNMUi002-A)
Donor diseases:
Schizophrenia
VUi005-A
(787.3)
Donor diseases:
Schizophrenia
VUi006-A
(SCZ 21.5)
Donor diseases:
Schizophrenia
VUi008-A
(SCZ 6.2)
Donor diseases:
Schizophrenia
VUi009-A
(SCZ 10.1)
Donor diseases:
Schizophrenia
VUi010-A
(SCZ 1.1)
Donor diseases:
Schizophrenia
VUi012-A
(SCZ 7.2)
Donor diseases:
Schizophrenia
VUi013-A
(804.3)
Donor diseases:
Schizophrenia
VUi015-A
(SCZ 12.1, hvs-477)
Donor diseases:
Schizophrenia
VUi017-A
(SCZ4.3)
Donor diseases:
Schizophrenia
VUi023-A
(801.A1, hvs474)
Donor diseases:
Schizophrenia
VUi024-A
(SCZ 9.4)
Donor diseases:
Schizophrenia
NMIi002-A
Donor diseases:
Schizophrenia
NMIi005-A
Donor diseases:
Schizophrenia
NMIi002-B
Donor diseases:
Schizophrenia
MHRCCGi001-A
(P1SH)
Donor diseases:
Schizophrenia
WCHi006-A
Donor diseases:
Schizophrenia
SZGJMSi001-A
(ZLP-2)
Donor diseases:
Schizophrenia
NMIi004-A
Donor diseases:
Schizophrenia
NMIi006-A
Donor diseases:
Schizophrenia
NMIi006-B
Donor diseases:
Schizophrenia
WCHi003-A
Donor diseases:
Schizophrenia
Last update 5th August 2025
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Vrije Universiteit Amsterdam (VU)
Distributors
Derivation country Netherlands

External Databases

BioSamples SAMEA6878071
Cellosaurus CVCL_ZB03
Wikidata Q98134613

General Information

* Is the cell line readily obtainable for third parties?
No

Donor Information

General Donor Information

Sex male

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
Synonyms
  • Schizophrenia
  • schizophrenia
  • Schizophrenia, unspecified

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
Yes

External Databases (Donor)

BioSamples SAMEA7762075

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? Yes
Do you (Depositor/Provider) hold the original Donor Consent Form? No
If you do not hold the Donor Consent Form, do you know who does? Yes
Alternatives to consent are available? Yes
Alternatives to consent Original swedish instead of english
Alternative consent approval number
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
* Does consent expressly prevent the derivation of pluripotent stem cells? No
* Does consent pertain to a specific research project? No
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? Yes
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? Swedish Ethical Review Authority
Approval number 2011-324-31 and 2012/214-32
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? Yes
Name of accrediting authority involved? Swedish Ethical Review Authority
Approval number 2011-324-31 and 2012/214-32
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

Source cell type

Reprogramming method

Vector type Non-integrating
Vector Episomal
Genes
Is reprogramming vector detectable?
Unknown

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Surface coating Vitronectin
Feeder cells
No
Passage method Enzyme-free cell dissociation
Gentle Cell Dissociation Reagent
O2 Concentration 5 %
CO2 Concentration 5 %
Medium TeSR™ E8™
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
OCT3/4
Yes
SSEA-4
Yes
Morphology pictures
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro directed differentiation
Marker Expressed
SOX17
Yes
Protocol or reference
Mesoderm
Ont Id: UBERON_0000926
In vitro directed differentiation
Marker Expressed
Brachyury
Yes
Protocol or reference
Ectoderm
Ont Id: UBERON_0000924
In vitro directed differentiation
Marker Expressed
Pax6
Yes
Protocol or reference

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
No

Other Genotyping (Cell Line)